Life-threatening bleeding after dental extraction in a hemophilia A patient with inhibitors to factor VIII: a case report.

作者: Max Heiland , Martin Weber , Rainer Schmelzle

DOI: 10.1016/S0278-2391(03)00739-0

关键词:

摘要: shape of the alveolar ridge could be redefined by orthodontic tooth movement assisted buccal corticotomies. Buccal corticotomies with have since been used our craniofacial team to correct problems in segment position and width. The treatment this patient illustrated how different types tissue-generating and-molding techniques can combined solve a particular clinical problem. Every procedure has set benefits complications. In case, additional surgery were helpful treating large palatal fistula, bilateral cleft maxillary segments, collapsed segments. References

参考文章(21)
R Schwaab, H-H Brackmann, C Meyer, J Seehafer, M Kirchgesser, A Haack, K Olek, E G D Tuddenham, J Oldenburg, Haemophilia A: mutation type determines risk of inhibitor formation. Thrombosis and Haemostasis. ,vol. 74, pp. 1402- 1406 ,(1995) , 10.1055/S-0038-1649954
Peter L. Turecek, Katalin Varadi, Herbert Gritsch, Wilfried Auer, Ludwig Pichler, Gerald Eder, Hans Peter Schwarz, Factor Xa and prothrombin: mechanism of action of FEIBA. Vox Sanguinis. ,vol. 77, pp. 72- 79 ,(1999) , 10.1159/000056722
C. R. M. Hay, Why do inhibitors arise in patients with haemophilia A British Journal of Haematology. ,vol. 105, pp. 584- 590 ,(1999) , 10.1046/J.1365-2141.1999.01396.X
K. A. Shastri, G. L. Logue, M. Y. Zeid, A. N. Behrens, E. J. Lenahan, J. G. Haar, Acquired factor VIII inhibitor with squamous cell cancer of the epiglottis. Archives of Otolaryngology-head & Neck Surgery. ,vol. 116, pp. 350- 353 ,(1990) , 10.1001/ARCHOTOL.1990.01870030114021
Alan G. Brox, Horace Laryea, Marc Pelletier, Successful treatment of acquired factor VIII inhibitors with cyclosporin American Journal of Hematology. ,vol. 57, pp. 87- 88 ,(1998) , 10.1002/(SICI)1096-8652(199801)57:1<87::AID-AJH17>3.0.CO;2-6
Brackmann, Lenk, Scharrer, Auerswald, Kreuz, German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies. Haemophilia. ,vol. 5, pp. 203- 206 ,(1999) , 10.1046/J.1365-2516.1999.00311.X
Louis Aledort, Inhibitors in hemophilia patients: Current status and management American Journal of Hematology. ,vol. 47, pp. 208- 217 ,(1994) , 10.1002/AJH.2830470312